sb 203580 has been researched along with pyrimidinones in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (pyrimidinones) | Trials (pyrimidinones) | Recent Studies (post-2010) (pyrimidinones) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 6,059 | 604 | 2,692 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CP; Chiu, YH; Guo, YC; Wang, HS | 1 |
1 other study(ies) available for sb 203580 and pyrimidinones
Article | Year |
---|---|
Interleukin-1β induces CXCR3-mediated chemotaxis to promote umbilical cord mesenchymal stem cell transendothelial migration.
Topics: Acetamides; Chemokine CXCL9; Chemotaxis; Coculture Techniques; Cycloheximide; Diffusion Chambers, Culture; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Imidazoles; Interleukin-1beta; Mesenchymal Stem Cells; p38 Mitogen-Activated Protein Kinases; Pyridines; Pyrimidinones; Receptors, CXCR3; RNA, Messenger; Umbilical Cord | 2018 |